{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:56:41Z","timestamp":1784073401379,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.micpath.2020.103975","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:53:11Z","timestamp":1578685991000},"page":"103975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Monoclonal antibodies against LipL32 confer prophylactic protection against lethal leptospirosis challenge in animal model"],"prefix":"10.1016","volume":"141","author":[{"given":"Charles Klazer","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta Dias","family":"Pacce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha Rodrigues","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Farias","family":"Collares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilton Clair","family":"Pinto Seixas Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Gon\u00e7alves","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odir Ant\u00f4nio","family":"Dellagostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane Drawanz","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.103975_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/CMR.14.2.296-326.2001","volume":"14","author":"Levett","year":"2001","journal-title":"Leptospirosis, Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2020.103975_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vetmic.2009.03.012","article-title":"Leptospira and leptospirosis","volume":"140","author":"Adler","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2020.103975_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4161\/hv.23059","article-title":"Whole-cell inactivated Leptospirosis vaccine: future prospects","volume":"9","author":"Verma","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2020.103975_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010158","article-title":"Reverse Vaccinology\u00a0: an approach for identifying leptospiral vaccine candidates","volume":"18","author":"Dellagostin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2020.103975_bib5","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1038\/srep15553","article-title":"Protective efficacy and mechanism of passive immunization with polyclonal antibodies in a sepsis model of Staphylococcus aureus infection","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2020.103975_bib6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/IAI.02897-14","article-title":"Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab","volume":"83","author":"Yang","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2020.103975_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.intimp.2018.01.035","article-title":"Passive immunization against methicillin resistant Staphylococcus aureus recombinant PBP2a in sepsis model of mice: comparable results with antibiotic therapy","volume":"56","author":"Naghshbandi","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2020.103975_bib8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jac\/dkr038","article-title":"Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection","volume":"66","author":"Secher","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2020.103975_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/hyb.2008.0056","article-title":"Monoclonal antibodies to LipL32 protect against heterologous leptospira spp. challenge","volume":"27","author":"Maneewatch","year":"2008","journal-title":"Hybridoma"},{"key":"10.1016\/j.micpath.2020.103975_bib10","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1038\/s41598-017-03658-0","article-title":"Peptide specific monoclonal antibodies of Leptospiral LigA for acute diagnosis of leptospirosis","volume":"7","author":"Kanagavel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2020.103975_bib11","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1016\/j.vaccine.2011.04.041","article-title":"Passive immunization with Leptospira LPS-specific agglutinating but not non-agglutinating monoclonal antibodies protect Guinea pigs from fatal pulmonary hemorrhages induced by serovar Copenhageni challenge","volume":"29","author":"Challa","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.103975_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/protein\/gzu006","article-title":"Therapeutic epitopes of Leptospira LipL32 protein and their characteristics","volume":"27","author":"Maneewatch","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.micpath.2020.103975_bib13","first-page":"2276","article-title":"The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection","volume":"68","author":"Haake","year":"2000"},{"key":"10.1016\/j.micpath.2020.103975_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jmb.2009.02.038","article-title":"Crystal structure of LipL32, the most abundant surface protein of pathogenic leptospira spp.","volume":"387","author":"Vivian","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2020.103975_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08184","article-title":"Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans","volume":"460","author":"Malmstr\u00f6m","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2020.103975_bib16","article-title":"Leptospira and leptospirosis","volume":"vol. 387","author":"Adler","year":"2015"},{"key":"10.1016\/j.micpath.2020.103975_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1139\/w06-138","article-title":"Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis","volume":"53","author":"Seixas","year":"2007","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.micpath.2020.103975_bib18","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","article-title":"The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis","volume":"25","author":"da Silva","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.103975_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/hyb.2006.033","article-title":"Monoclonal antibodies against LipL32, the major outer membrane protein of pathogenic leptospira: production, characterization, and testing in diagnostic applications","volume":"26","author":"Fernandes","year":"2007","journal-title":"Hybridoma"},{"key":"10.1016\/j.micpath.2020.103975_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.09.105","article-title":"Monoclonal antibody-based therapies for microbial diseases","volume":"27","author":"Saylor","year":"2009","journal-title":"Vaccine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401019316602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401019316602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:26:57Z","timestamp":1760110017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401019316602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":20,"alternative-id":["S0882401019316602"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.103975","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibodies against LipL32 confer prophylactic protection against lethal leptospirosis challenge in animal model","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.103975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103975"}}